Sherry Hsieh

Staff Reporter

Email: hsieh@ocbj.com
Phone: 949-833-8373 Extension: 242

Recent Stories

Health Technology Applications Blaze Treatment Trails

Hospitals Leading on AI, Data, Machine Learning

AI. Machine learning. Hospitals and healthcare.

Cryoport Opens Global Logistics Facility in Amsterdam

Endologix’s Bad News; Masimo’s New Software

Cryoport Inc. (Nasdaq: CYRX), the Irvine-based cold-chain shipping logistics provider, is riding the gene and cell therapy development boom.

Outpatients Push Healthy 7% Hospital Revenue Hike

UCI, Kaiser, Hoag: $3B, 37% of List’s Net Revenue

Orange County hospitals grew net patient revenue 7% year-over-year to $8.5 billion, largely due to the continuing move toward more outpatient visits.

Healthcare Q&A

Healthcare continues to move beyond the four walls—and multiple floors— of a hospital. Reasons for the “outpatient migration” to ambulatory care sites, other nontraditional locales and even into the home flow from personalization in care, cost savings, socioeconomic factors and lifestyle changes, all keyed to the goal of determining optimum treatment.

Midday Stock Roundup

The S&P 500 was flat at 2,752.55.

Tease photo

Evolus Gets FDA Nod For First Product

HEALTHCARE: Stock surges, new hires on tap

Shares of Evolus Inc. increased nearly 70% in the week after the Newport Beach-based company announced it won regulatory approval to sell a cheaper version of Allergan PLC’s best-known product, Botox.

Tease photo

Nonprofit CFO Sharifi Embraces For-Profit Mindset

Expands Radiant to Generate Revenue

Guita Sharifi believes a nonprofit should run like a business, albeit with room for tears and fun.

Hoag Orthopedic Expands Into Physical Therapy

UCI Health Boss Starts; BioCoRx Wins Grant

Hoag Orthopedic Institute, which operates under a joint venture between Hoag Memorial Presbyterian Hospital and a physician group, is expanding.

Midday Stock Roundup

The S&P 500 was down 1.5% for 2,689.74.

Tease photo

Biogennix names CFO

Biogennix, an Irvine-based maker of bone graft substitutes, appointed Robert Baizer as its first chief financial officer.

Tease photo

More stories >>